Baird Medical Investment Holdings Limited (BDMD) — Cash Flow Reinvestment Rate

Latest as of June 2023: 1.97x

Baird Medical Investment Holdings Limited (BDMD) has a Cash Flow Reinvestment Rate of 1.97x as of June 2023, reinvesting $1.26 Million (capex $1.26 Million ) from operating cash flow of $642.95K. Check earnings quality score of Baird Medical Investment Holdings Limite to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.97x
(Capex + Investments) / Operating CF

Total Reinvested

$1.26 Million
Capex + Investments

Operating Cash Flow

$642.95K
USD

Capital Expenditures

$1.26 Million
USD

Baird Medical Investment Holdings Limited Cash Flow Reinvestment Rate (2019–2022)

Historical reinvestment intensity for Baird Medical Investment Holdings Limited across 4 annual periods. Explore cash flow to debt ratio of Baird Medical Investment Holdings Limite to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Baird Medical Investment Holdings Limited (2019–2022)

Year-by-year capital reinvestment analysis for Baird Medical Investment Holdings Limited. For live market cap and broader valuation context, see how much is Baird Medical Investment Holdings Limite worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2022 24.44x $11.88 Million $485.97K $5.95 Million ▲ +4528.2%
2021 0.53x $2.77 Million $5.26 Million $1.39 Million ▲ +214.8%
2020 0.17x $655.35K $3.91 Million $655.35K ▼ -24.8%
2019 0.22x $983.78K $4.41 Million $983.78K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow